Conjugate vaccine for group B Streptococcus
AssigneesThe General Hospital Corporation, The Brigham and Women's Hospital, Inc.
InventorsJames L. Michel, Dennis L. Kasper, Frederick M. Ausubel, Lawrence C. Madoff
Life of this patent
Estimating the term…
Abstract
A vaccine capable of protecting a recipient from infection caused by group B Streptococcus. The vaccine provides polysaccharide-protein moieties and contain (a) a group B Streptococcus polysaccharide conjugated to (b) a functional derivative of a group B Streptococcus C protein alpha antigen that retains the ability to elicit protective antibodies against group B Streptococcus. The vaccine may contain only one type of such polysaccharide-protein unit or may contain a mixture of more than one type of unit.
Claims17
A protein of group B Streptococcus wherein said protein is selected from the group consisting of a purified S1 protein and a purified S23 protein.
A purified group B Streptococcus .alpha.-antigen protein comprising the amino acid sequence of SEQ ID No:
- 15 or an antibody eliciting fragment thereof.
A purified group B Streptococcus .alpha.-antigen protein or an antibody eliciting fragment thereof, wherein said protein or antibody eliciting fragment thereof comprises the amino acid sequence represent by at least one member selected from the group consisting of N, C, N-C, R.sub.1, R.sub.2, R.sub.3, R.sub.4, R.sub.5, R.sub.6, R.sub.7, R.sub.8, R.sub.9, R.sub.9', R.sub.x, N-R.sub.1, N-R.sub.2, N-R.sub.3, N-R.sub.4, N-R.sub.5, N-R.sub.6, N-R.sub.7, N-R.sub.8, N-R.sub.9, N-R.sub.9', N-R.sub.x, R.sub.1 -C, R.sub.2 -C, R.sub.3 -C, R.sub.4 -C, R.sub.5 -C, R.sub.6 -C, R.sub.7 -C, R.sub.8 -C, R.sub.9 -C, R.sub.9' -C, R.sub.x -C, N-R.sub.1 -C, N-R.sub.2 -C, N-R.sub.3 -C, N-R.sub.4 -C, N-R.sub.5 -C, N-R.sub.6 -C, N-R.sub.7 -C, N-R.sub.8 -C, N-R.sub.9 -C, N-R.sub.9' -C, and N-R.sub.x -C where "X" is 10 or greater, where "N" is the N-terninal sequence that precedes the start of the alpha antigen repeating unit sequence that is found in the sequence shown on FIG. 6 (SEQ ID NO:15), with or without the signal sequence, "C" is the 48 amino acid C-terminal anchor sequence as shown on FIG. 6 (SEQ ID NO:15), "R" is one copy of the 82 amino acids 227-308 of the DNA sequence of FIG. 6 (SEQ ID NO:15), and "R.sub.x " is "X" number of tandem copies of this repeat, tandemly joined at the carboxyl end of one R unit to the amino terminal end of the adjoining R unit, and 9' represents the sequence of amino acids 227-975 as shown in FIG. 6 (SEQ ID NO:15).
A purified protein comprising the amino acid sequence of a group BStreptococcus .alpha.-antigen wherein said amino acid sequence is shown on FIG. 6 or an antibody-eliciting fragment of the sequence shown on FIG. 6 (SEQ ID No:15).
Dependencies are inferred from the claim text.